Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.
Ridgway H, Moore GJ, Gadanec LK, Zulli A, Apostolopoulos V, Hoffmann W, Węgrzyn K, Vassilaki N, Mpekoulis G, Zouridakis M, Giastas P, Vidali VP, Kelaidonis K, Matsoukas MT, Dimitriou M, Mavromoustakos T, Tsiodras S, Gorgoulis VG, Karakasiliotis I, Chasapis CT, Matsoukas JM.
Ridgway H, et al. Among authors: gadanec lk.
Expert Opin Ther Targets. 2024 Jun 3. doi: 10.1080/14728222.2024.2362675. Online ahead of print.
Expert Opin Ther Targets. 2024.
PMID: 38828744